Wordt geladen...
Lymphocyte‐Bound Complement Activation Products as Biomarkers for Diagnosis of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is frequently misdiagnosed due to the lack of definitive diagnostic tests. The purpose of this study was to determine specifically whether complement activation products (CAP) are deposited on lymphocytes of SLE patients and whether lymphocyte‐bound CAP (LB‐CAP) ma...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Inc
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2790176/ https://ncbi.nlm.nih.gov/pubmed/20161444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1752-8062.2009.00135.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|